GlassScriptPhysician profile
Ariel J Ourian
NPI 1932469954
$6,832.81
in general payments reported to CMS, 2019-2025
15 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $257 · 2021: $2,608 · 2022: $2,131 · 2023: $376 · 2024: $859 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $4,407.46 | 2021-2022 | |
| Abbvie INC. | $664.32 | 2023-2025 | |
| Integra Lifesciences Corporation | $410.75 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nevro Corp. | $290.72 | 2024 | Senza |
| Tela Bio, INC. | $276.21 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $177.76 | 2021-2022 | |
| Penumbra, INC. | $155.97 | 2025 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.26 | 2024 | Jardiance |
| Motiva USA, LLC | $101.41 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.28 | 2023 | Lifevest |
| Mentor Worldwide LLC | $41.79 | 2025 | Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Vertex Pharmaceuticals Incorporated | $32.54 | 2025 | |
| Galderma Laboratories, L.P. | $31.08 | 2021-2022 | |
| Polynovo North America LLC | $14.51 | 2024 | Novosorb Btm |
| Itamar Medical INC | $13.75 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Ourian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.